Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Inhibition of Cdk Activity
Bone Remodeling
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 22, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Philipp Vinzenz1,2, Stefan Schröckmair1,2, Reinhard Gruber1,2,3
1Department of Oral Surgery, Medical University of Vienna, Austria.
Bone substitute materials releasing prolyl hydroxylase inhibitors were found to reduce osteoclastogenesis. These inhibitors decrease osteoclast formation and activity, impacting bone regeneration positively.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: